Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,217 | -68,480 | -47,462 | -27,142 | -50,274 |
| Depreciation Amortization | 1,405 | 1,073 | 739 | 384 | 1,232 |
| Accounts payable and accrued liabilities | 26,102 | 7,330 | -799 | -723 | N/A |
| Other Working Capital | 35,270 | 27,570 | 21,795 | 12,574 | 3,908 |
| Other Operating Activity | -20,188 | -3,353 | 2,922 | 1,274 | -2,011 |
| Operating Cash Flow | $-46,628 | $-35,860 | $-22,805 | $-13,633 | $-47,145 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,105 | -383 | -404 | -349 | -1,195 |
| Investing Cash Flow | $-1,105 | $-383 | $-404 | $-349 | $-1,195 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 264,007 | 267,375 | 267,375 | N/A | N/A |
| Debt Repayment | -61 | -61 | -61 | -60 | N/A |
| Common Stock Issued | 1,045 | 490 | 382 | 85 | N/A |
| Other Financing Activity | 109,879 | 106,511 | 106,583 | 109,772 | 41,567 |
| Financing Cash Flow | $374,870 | $374,315 | $374,279 | $109,797 | $41,567 |
| Exchange Rate Effect | 87 | N/A | N/A | N/A | -341 |
| Beginning Cash Position | 58,976 | 58,976 | 58,976 | 58,976 | 66,090 |
| End Cash Position | 386,200 | 397,048 | 410,046 | 154,791 | 58,976 |
| Net Cash Flow | $327,224 | $338,072 | $351,070 | $95,815 | $-7,114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,628 | -35,860 | -22,805 | -13,633 | -47,145 |
| Capital Expenditure | -1,155 | -433 | -404 | -349 | N/A |
| Free Cash Flow | -47,783 | -36,293 | -23,209 | -13,982 | -47,145 |